MELANIE WHITESELL: Open Payments
NPI 1245825439 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$953 in 11 payments from 6 companies in 2025. Trend: 2023 $981 · 2024 $240 · 2025 $953
Food & beverage: $953
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 2 | $246 |
| E.R. Squibb & Sons, L.L.C. | 2 | $243 |
| Neurocrine BioSciences, Inc. | 3 | $223 |
| Luye Pharma (USA) Ltd. | 1 | $108 |
| Janssen Pharmaceuticals, Inc | 1 | $96 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
Products named: AUSTEDO XR, COBENFY, INGREZZA, ERZOFRI EXTENDED-RELEASE, INVEGA SUSTENNA, REXULTI.
Industry payments across NC — which companies pay providers there.
